Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Gynecologic Oncology

RSS  

Articles

  • STI Quarterly: Seniors may be older and wiser, but don't assume they know STI risks

    If your clinical practice includes the care of age 50-plus women, are you including information on risks for sexually transmitted infections (STIs)? You should.
  • Teen Topics: EPT: Use it to reduce STI teen reinfection

    According to the Centers for Disease Control and Prevention, female adolescents have the highest number of cases of gonorrhea and chlamydia in the United States.1 While the overall prevalence for these infections among individuals ages 14-39 are .24% and 2.2% respectively, these rates are .92% and 3.4% for those ages 14-19.2
  • FDA schedules review of drospirenone pills

    The Food and Drug Administration (FDA) has scheduled a Dec. 8, 2011, meeting of its Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee to review the risks and benefits of oral contraceptives containing the progestin drospirenone. The agency is weighing evidence regarding the risk of increased blood clots in users of such pills.
  • OB/GYN Quarterly Update: What healthcare providers should know about detecting thyroidal conditions

    Thyroid dysfunction and disease might present as reproductive compromise including oligomenorrhea, infertility, and miscarriage.
  • More condom use by teen males reported

    The safer sex message is reaching adolescents. Results of a new Centers for Disease Control and Prevention (CDC) report shows the percentage of teen males ages 15-19 in the United States who used a condom the first time they had sex increased between 2002 and 2006-2010.
  • New data emerges on one-size diaphragm

    The contraceptive options for women who cannot use hormonal methods might soon expand if regulatory approval is given to a new single-size diaphragm. Results of a two-year multi-site study of 450 U.S. couples indicate the effectiveness rates of the SILCS single size, contoured diaphragm, now in development, are similar to traditional diaphragms.
  • Just in: IUDs reduce cervical cancer risk

    To perform the study, researchers designed a pooled analysis of individual data from two large studies by the International Agency for Research on Cancer, an international collaboration on cancer research, and the Institut Català d'Oncologia, a Spanish-based oncology research program.
  • The Relevance of FLT3 in APL

    The prognostic relevance of fms-like tyrosine kinase 3 (FLT3) internal tandem duplications and point mutations at D835 in acute promeylocytic leukemia (APL) is controversial.
  • Incidental Adrenal Mass

    A 70-year-old man undergoing preoperative evaluation for abdominal aortic aneurysm surgery was noted to have a 3 cm mass in the right adrenal gland with heterogeneous texture but clear margins.
  • Timing of Influenza Vaccination in Patients Receiving Chemotherapy

    For patients in the midst of chemotherapy, there are little data on the most efficacious time to administer influenza vaccine. In a randomized study of 38 patients receiving FEC chemotherapy for adjuvant treatment of breast cancer, it is apparent that vaccination early (on day 4 of a 21-day cycle) provided better antibody response than when administered late in the cycle (day 16).